Animal models of hearing loss and human clinical trials are actively testing a strategy that combines antioxidant treatments to deliver better ROS scavenging (Gilles et al
5) Liver Health: Addressing Non-Alcoholic Fatty Liver Disease (NAFLD) GLP-1 medications are demonstrating efficacy in managing NAFLD, a growing public health concern often associated with obesity, insulin resistance, and Type 2 diabetes
As will all medications, semaglutide is not entirely risk-free
Bottom line: Whether you choose morning or night, the goal is to keep your cellular levels stable over time
Why this matters here: the researchers who did the original human topical delivery work weren't treating injection as the obviously superior route being compared against a weaker alternative
While ashwagandha and rhodiola seem to have the most research backing them, magnesium is also the least expensive place to begin